Valeritas Stock Price - VLRX

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 0.70 ▼ -0.03 (-3.63%)
Company Name Stock Ticker Symbol Market Type
Valeritas Holdings Inc VLRX NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.0555 -7.07% 0.73 0.798 0.70 0.786 0.7855 17:02:20
Bid Price Ask Price Spread Spread % News
0.7035 0.7495 0.046 6.14% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
597 297,654 $ 0.7555563 $ 224,894 395,967 0.2101 - 5.69
Last Trade Time Type Quantity Stock Price Currency
17:02:29 formt 1,870 $ 0.7035 USD

Valeritas Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 6.08M 8.33M $ -45.93M -48.37 2.80 7.92M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Valeritas News

Loading Messages....

Latest VLRX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VLRX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.6690.840.640.7609876644,6480.0619.12%
1 Month0.650.840.550.6751879463,6120.0812.31%
3 Months1.501.840.550.8859609281,903-0.77-51.33%
6 Months2.733.630.551.61302,544-2.00-73.26%
1 Year0.4215.690.21011.15777,8240.30973.4%
3 Years9.509.500.21011.20595,700-8.77-92.32%
5 Years9.509.500.21011.20595,700-8.77-92.32%

Valeritas Description

Valeritas Holdings Inc is a commercial-stage medical technology company. It is engaged in the business of improving health and simplifying life for diabetic patients by developing and commercializing innovative technologies. The company designed its first commercialized product, the V-Go Wearable Insulin Delivery Device, or V-Go, that supports the patients with Type 2 diabetes who need insulin to achieve and maintain their target blood glucose goals. V-Go is a small easy-to-use disposable insulin delivery device that a patient wears on his or her skin every 24 hours. It commenced commercial sales of V-Go first in the US and has a sales footprint spread across the country. The company primarily generates its revenues in the United States.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.